Jorge S Reis-Filho
Jorge S Reis-Filho is an expert in Oncology at Memorial Sloan Kettering Cancer Center (United States). As of September 2026, ScienceLeadR ranks Jorge S Reis-Filho in the top 1% of experts worldwide for Breast Diseases, Breast Neoplasms and Carcinoma. Jorge S Reis-Filho has authored 965 publications, the most recent in 2025, and is an investigator in 11 clinical trials. SLR score: 3,273 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Genetics - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2025
Number : 965
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors. PMID 40705098 — genes, poly(adp-ribose) polymerases, epigenomics, neoplasms, biopsy, poly adenosine diphosphate ribose, therapeutics, dna, liquid biopsy, dna damage | Clin Cancer Res | 2025 | 0 |
| Evolution and co-occurrence of PI3K pathway gene mutations in endometrial carcinoma molecular subtypes at the single-cell level. PMID 40833784 — cells, genes, neoplasms, therapeutics, mutation | Clin Cancer Res | 2025 | 0 |
| Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test. PMID 40338593 — research design, retinoblastoma, mosaicism, aftercare, alleles, diagnosis, eye diseases, therapeutics, plasma | JAMA Ophthalmol | 2025 | 2 |
| Genomic landscape of breast cancer in elderly patients. PMID 40640183 — breast neoplasms, neoplasms, aged, breast, therapeutics, mutation | NPJ Breast Cancer | 2025 | 0 |
| APOBEC3 mutagenesis drives therapy resistance in breast cancer. PMID 40379787 — breast neoplasms, mutagenesis, neoplasms, hormones, enzymes, breast, therapeutics | Nat Genet | 2025 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map